1. Home
  2. SHIM vs NRXP Comparison

SHIM vs NRXP Comparison

Compare SHIM & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shimmick Corporation

SHIM

Shimmick Corporation

HOLD

Current Price

$3.47

Market Cap

160.8M

Sector

N/A

ML Signal

HOLD

Logo NRX Pharmaceuticals Inc.

NRXP

NRX Pharmaceuticals Inc.

HOLD

Current Price

$3.37

Market Cap

151.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHIM
NRXP
Founded
1990
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.8M
151.1M
IPO Year
2023
2017

Fundamental Metrics

Financial Performance
Metric
SHIM
NRXP
Price
$3.47
$3.37
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$38.25
AVG Volume (30 Days)
178.6K
733.7K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
81.95
69.70
EPS
N/A
N/A
Revenue
$492,844,000.00
$1,225,000.00
Revenue This Year
$13.99
$2,547.84
Revenue Next Year
$6.94
$1,591.73
P/E Ratio
N/A
N/A
Revenue Growth
2.63
N/A
52 Week Low
$1.95
$1.65
52 Week High
$6.76
$5.06

Technical Indicators

Market Signals
Indicator
SHIM
NRXP
Relative Strength Index (RSI) 42.98 45.31
Support Level $3.42 $3.09
Resistance Level $4.13 $3.50
Average True Range (ATR) 0.28 0.15
MACD -0.02 0.01
Stochastic Oscillator 28.51 13.89

Price Performance

Historical Comparison
SHIM
NRXP

About SHIM Shimmick Corporation

Shimmick Corp is engaged in delivering turnkey infrastructure solutions that strengthen critical markets across water, energy, climate resiliency, and sustainable transportation. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains critical infrastructure, including mass transit, bridges, and military infrastructure. The company has one operating and reportable segment: infrastructure solutions. All of its revenue is derived from the United States.

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Share on Social Networks: